₹220 per shot, a health revolution: Eris unlocks next-gen diabetes care for millions
Game-changing weekly semaglutide therapy launched at unprecedented affordability ‘SUNDAE’ aims to bring advanced GLP-1 treatment within reach of 70% of ...
Game-changing weekly semaglutide therapy launched at unprecedented affordability ‘SUNDAE’ aims to bring advanced GLP-1 treatment within reach of 70% of ...
